VSEE

VSee Health, Inc.
NASDAQHEALTHCAREHEALTH INFORMATION SERVICES

Key Statistics

Market Cap
$5.35M
P/E Ratio
EPS
$-0.54
Beta
0.49
52W High
$1.63
52W Low
$0.10
50-Day MA
$0.16
200-Day MA
$0.40
Dividend Yield
Profit Margin
-92.40%
Forward P/E
PEG Ratio

About VSee Health, Inc.

VSee Health, Inc. is a leading innovator in the telehealth sector, providing secure video communication solutions tailored for healthcare providers and patients alike. Its comprehensive platform enhances care delivery through features such as remote patient monitoring, asynchronous messaging, and seamless EMR integration, thereby bolstering efficiency and quality across various medical disciplines. As the demand for virtual care surges in the evolving healthcare landscape, VSee's commitment to patient engagement and accessibility positions it strategically for significant growth. With a focus on innovation and client success, VSee Health is well-prepared to capitalize on the expanding digital healthcare market.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$14.46M
Gross Profit (TTM)$6.69M
EBITDA$-8.14M
Operating Margin-94.10%
Return on Equity-946.00%
Return on Assets-34.90%
Revenue/Share (TTM)$0.52
Book Value$-0.33
Price-to-Book0.87
Price-to-Sales (TTM)0.37
EV/Revenue0.434
EV/EBITDA
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)-4.90%
Shares Outstanding$48.60M
Float$37.69M
% Insiders10.41%
% Institutions10.65%

Historical Volatility

HV 10-Day
57.38%
HV 20-Day
74.82%
HV 30-Day
128.75%
HV 60-Day
99.81%
HV Rank

Volatility is currently contracting

Latest News

VSee Health CEO Issues Shareholder Update as Company Focuses on iDoc TeleHealth Solutions for Revenue Growth and Profitability

HOUSTON, TX / ACCESS Newswire / July 9, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today issued the following letter from Chairman and Chief Executive Officer Dr. Imoigele Aisiku providing shareholders with an update on the Company's strategic transformation and outlook. Dear Fellow Shareholders, Over the past two years, VSee Health has undergone a significant transformation.

Accesswire7/9/2026Neutral
VSee Health Realizes 20X Expansion of its Hospital Network to 58 Locations

Key Driver for its Enterprise Telehealth Revenue Acceleration HOUSTON, TX / ACCESS Newswire / June 25, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, is pleased to announce that its hospital footprint has grown to 58 locations, up from just 3 in approximately two tears. This dramatic ramp of 20-fold over the past two years, has led to a significant +80% growth in revenue in 2025 to $11.4 million.

Accesswire6/25/2026Neutral
VSee Health Highlights Business Operations and Financial Success After Recent Strategic Sale

Refocus on Telehealth and Digital Health Solutions That Provided 80% Revenue Growth in 2025 HOUSTON, TX / ACCESS Newswire / June 22, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solution, is pleased to provide an update on its business operations and financial success following its strategic sale of VSee Lab on May 31, 2026. Pro-forma financials from enhanced focus on iDoc telehealth platform and enterprise healthcare solutions: +60% revenue growth to $8 million in 2025 +70% revenue growth to $2.5 million in Q1 2026 Approximate reduction of $6.0 million in annual operating expenses Several large IDN (Integrated Health Network) multi-year contracts that were signed throughout 2025 are continuing to roll out, build revenue and add more telehealth services.

Accesswire6/22/2026Neutral
VSee Health Completes Strategic Separation of VSee Lab, Retires Approximately 7% of Outstanding Shares, and Transitions to Single CEO Leadership

HOUSTON, TX / ACCESS Newswire / June 11, 2026 / VSee Health, Inc. (NASDAQ:VSEE) today announced the completion of a transformative strategic transaction that separates the Company from its former laboratory subsidiary, VSee Lab, eliminates a significant block of outstanding shares, and positions VSee Health to focus exclusively on its core telehealth and digital health platform businesses. Under a Stock Purchase Agreement dated May 31, 2026, VSee Health sold 100% of VSee Lab, Inc. to former Co-Chief Executive Officer and Chairman Milton Chen.

Accesswire6/11/2026Neutral

More HEALTHCARE Stocks

Data last updated: 7/9/2026